Carlos Cruz Teran
About Carlos Cruz Teran
Carlos Cruz Teran is a Development Scientist at Locus Biosciences, Inc., specializing in gene therapy and antibody engineering. He has extensive experience in protein engineering and has held various academic positions, including postdoctoral researcher and teaching assistant.
Current Role at Locus Biosciences
Carlos Cruz Teran serves as a Development Scientist at Locus Biosciences, Inc. since 2021. In this role, he focuses on developing reagents to overcome immunity against adeno-associated virus (AAV) for gene therapy. His current research also includes engineering antibodies against viruses and developing technologies for gene delivery into commensal bacteria. His work contributes to advancing gene therapy techniques and enhancing the efficacy of therapeutic interventions.
Education and Academic Background
Carlos Cruz Teran completed his Bachelor's Degree at The University of New Mexico from 2007 to 2011. He then pursued a Master's Degree at North Carolina State University from 2011 to 2013. Following this, he achieved a Doctor of Philosophy (Ph.D.) at North Carolina State University from 2011 to 2017. His graduate research concentrated on protein engineering, combinatorial library design, and the isolation of novel binders.
Professional Experience in Research
Carlos has extensive research experience in various academic institutions. He worked as a Graduate Teaching Assistant at North Carolina State University in Yeast Metabolic Engineering and Bio-nanomaterials in 2014 and 2015, respectively. He served as a Research Assistant in Protein Engineering at North Carolina State University from 2011 to 2017. Additionally, he was a Postdoctoral Researcher at the UNC Eshelman School of Pharmacy from 2017 to 2021, where he focused on advancing research in gene therapy.
Skills and Expertise
Carlos Cruz Teran possesses a range of technical skills relevant to his research. He is proficient in protein and virus purification and characterization, as well as molecular biology techniques. He has experience in fluorescent activated cell sorting, bio-assay development, and transduction development. His expertise also includes yeast surface display and ribosome display techniques, contributing to his comprehensive understanding of protein engineering and gene therapy.
Achievements and Recognition
Carlos is recognized for his contributions to research in gene therapy, having received the Pfizer-NCBiotech Distinguished Postdoctoral Fellowship for Advancement of Research in Gene Therapy. He has a proven record in grant writing, which supports his research initiatives and enhances funding opportunities for scientific projects.